【24h】

Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery.

机译:术后六个月的生活质量可预测食道癌手术后的长期生存率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Patients treated with curatively intended surgery for oesophageal cancer have an approximately 30% chance of 5-year survival. Little is known about associations between postoperative health-related quality of life (HRQL) and long-term survival. HYPOTHESIS: Poor postoperative HRQL after curatively intended oesophageal cancer surgery is associated with a reduced long-term survival. METHODS: A Swedish nationwide cohort of oesophageal cancer patients, treated surgically between 2001 and 2005, was followed up until death or end of August 2009. Nine HRQL aspects were selected for analyses from EORTC QLQ-C30 and QLQ-OES18 questionnaires answered 6 months postoperatively. The HRQL measures were categorised into two groups: 'good function' versus 'poor function' and 'no or minor symptoms' versus 'symptomatic'. Associations between HRQL and survival were analysed using Cox proportional hazard ratios (HR) and 95% confidence intervals (CIs), adjusted for potential confounding factors. FINDINGS: All 401 oesophageal cancer patients who survived at least 6 months postoperatively and responded to the questionnaires were included. For each of the nine selected outcomes, poor scores were associated with an increased hazard ratio of mortality: global HRQL (HR=1.55; 95% CI 1.19-2:02), physical function (HR=1.56; 95% CI 1.23-1.99), social function (HR=1.52; 95% CI 1.19-1.94), fatigue (HR=1.65; 95% CI 1.30-2.11), pain (HR=1.45; 95% CI 1.22-1.87), dyspnoea (HR=1.54; 95% CI 1.19-2.01), appetite loss (HR=1.69; 95% CI 1.32-2.14), dysphagia (HR=1.69; 95% CI 1.13-2.51) and oesophageal pain (HR=1.29; 95% CI 1.02-1.65). INTERPRETATIONS: HRQL assessed 6 months after oesophageal cancer surgery can be used as a clinically useful prognostic factor.
机译:背景:接受食管癌根治性手术治疗的患者5年生存率约为30%。关于术后健康相关的生活质量(HRQL)和长期生存之间的关联知之甚少。假设:食管癌根治性手术后的术后HRQL差与长期生存率降低有关。方法:对瑞典全国范围内的一组食管癌患者进行手术治疗,随访时间从2001年至2005年,直至死亡或2009年8月。从EORTC QLQ-C30和QLQ-OES18问卷中选择了9个HRQL进行了术后6个月的回答。 HRQL措施分为两类:“良好功能”与“不良功能”以及“无或轻微症状”与“有症状”。使用Cox比例风险比(HR)和95%置信区间(CIs)对HRQL与生存之间的关联进行了分析,并针对潜在的混杂因素进行了调整。结果:所有401例食管癌患者均在术后至少6个月生存并且对调查表作出了回应。对于九个选定结局中的每一个,评分差均与死亡率的危险比增加相关:整体HRQL(HR = 1.55; 95%CI 1.19-2:02),身体机能(HR = 1.56; 95%CI 1.23-1.99 ),社交功能(HR = 1.52; 95%CI 1.19-1.94),疲劳(HR = 1.65; 95%CI 1.30-2.11),疼痛(HR = 1.45; 95%CI 1.22-1.87),呼吸困难(HR = 1.54) ; 95%CI 1.19-2.01),食欲不振(HR = 1.69; 95%CI 1.32-2.14),吞咽困难(HR = 1.69; 95%CI 1.13-2.51)和食道疼痛(HR = 1.29; 95%CI 1.02- 1.65)。解释:食管癌手术后6个月评估的HRQL可用作临床有用的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号